Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 studyAnthony R. Mato, Michael Wang, John M. Pagel et al.|The Lancet|2021Cited by 456
Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patientsMatthew R. Wilson, Fiona Miall, Toby A. Eyre et al.|UCL Discovery (University College London)|2022Cited by 76